About Aspect Biosystems

Aspect Biosystems is a biotechnology company developing bioprinted tissue therapeutics to transform how we treat disease. By combining its proprietary microfluidic 3D bioprinting technology, therapeutic cells, and materials science, Aspect is creating a pipeline of allogeneic cell-based tissue therapeutics to replace or repair damaged organ functions. The company is also partnering with leading researchers and industry innovators worldwide to tackle the biggest challenges in regenerative medicin

Repeat Founder
Company Highlights
Year Founded

2013

icon-altEmployees

108

Location (HQ)

CAN

Since Last Funding

1 year 5 months

Monthly Website Visitors

12.8K

icon-altTotal Investment Amt

$28M

Last Funding Round

Grant

icon-altMoM Headcount Growth

0.93%

icon-altYoY Headcount Growth

25.55%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Biotechnology

Life Science

3D Printing